Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning.
Kasamon YL, Wahl RL, Ziessman HA, Blackford AL, Goodman SN, Fidyk CA, Rogers KM, Bolaños-Meade J, Borowitz MJ, Ambinder RF, Jones RJ, Swinnen LJ.
Kasamon YL, et al. Among authors: borowitz mj.
Biol Blood Marrow Transplant. 2009 Feb;15(2):242-8. doi: 10.1016/j.bbmt.2008.11.026.
Biol Blood Marrow Transplant. 2009.
PMID: 19167684
Free PMC article.
Clinical Trial.